Starling Oncology, Inc. Deferred Tax Asset, Interest Carryforward
Starling Oncology, Inc. (STLN) had Deferred Tax Asset, Interest Carryforward of $0 as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetInterestCarryforward · last filed 2024-03-28
- 2023-12-31: Deferred Tax Asset, Interest Carryforward $0.00.
- 2022-12-31: Deferred Tax Asset, Interest Carryforward $21.00K.
- 2021-12-31: Deferred Tax Asset, Interest Carryforward $0.00.
| Period end | Deferred Tax Asset, Interest Carryforward |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2022-12-31 | $21.00K 10-K · filed 2024-03-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |